Duality Advisers, LP Bausch Health Companies Inc. Transaction History

Duality Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$6.53 - $8.23 $97,956 - $123,458	15,001 Added 20.42%	88,449 $709,000
Q3 2023 Nov 02, 2023	SELL	$7.69 - $9.71 $261,483 - $330,169	-34,003 Reduced 31.65%	73,448 $603,000
Q2 2023 Jul 31, 2023	SELL	$5.72 - $8.8 $244,049 - $375,460	-42,666 Reduced 28.42%	107,451 $859,000
Q1 2023 Jun 27, 2023	SELL	$6.28 - $9.85 $269,336 - $422,446	-42,888 Reduced 22.22%	150,117 $1.22 Million
Q4 2022 Feb 07, 2023	BUY	$6.09 - $7.93 $1.18 Million - $1.53 Million	193,005 New	193,005 $1.21 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.